StockWatch
·
Pharmaceuticals
Quarterly Result5 Nov 2026, 08:11 pm

Gujarat Inject Kerala Ltd Q2 FY27 Results Approved

AI Summary

Gujarat Inject (Kerala) Limited announced its unaudited financial results for the second quarter and half-year ended September 30, 2026. The Board of Directors approved these results and the limited review report from S. Mandawat & Co. The company also reported a significant corporate action: a preferential issue of 3,00,00,000 Equity Warrants aggregating up to ₹3,00,00,000 (₹3 Crore) to non-promoters/public. Additionally, the Solar Power Generation Project Plant has been capitalized as Property, Plant & Equipment. The company's equity shares were also sub-divided during the quarter.

Key Highlights

  • Unaudited financial results for Q2 and H1 FY27 approved.
  • Limited review report from statutory auditors taken on record.
  • Board approved preferential issue of equity warrants worth ₹3 Crore.
  • Solar Power Generation Project capitalized as PPE.
  • Equity shares sub-divided during the quarter.